Biologically important modes of polypeptide assembly
Biologically important modes of polypeptide assembly
批准号:
9973889
负责人:
SAMUEL H. GELLMAN
金额:
$36.11万
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-06-01 至 2024-05-31
关键词:
AddressAdoptedAdoptionAlzheimer&aposs DiseaseAlzheimer&aposs disease brainAmino Acid SequenceAmyloidAmyloid FibrilsAmyloid beta-Protein PrecursorAmyloidosisAreaBiologicalBiological ModelsBiological ProcessBiologyCell Membrane ProteinsCell Surface ReceptorsCell physiologyCellsChemicalsCollaborationsComplexCryoelectron MicroscopyCrystallizationDataDepositionDimensionsDiseaseFamilyFoundationsFutureGenerationsGeometryGoalsHealthHumanHydrophobic InteractionsHydrophobicityImmunologic ReceptorsLeadLearningLinkLipid BilayersLiquid substanceMediatingMembraneMethodsMicro Electron DiffractionModelingMolecular ConformationPathogenicityPathologicPeptidesPhaseProtein FamilyProtein RegionProteinsReceptor ActivationReceptor Protein-Tyrosine KinasesResearchResolutionRoleSAP-A ProteinSignal TransductionStructureSystemT-Cell ReceptorTYROBP geneTechniquesTestingWorkX ray diffraction analysisalpha helixamyloid formationbasebeta pleated sheetchemical synthesisdesigndimerhuman diseasein vivointerestpolypeptideprogramsprotein aminoacid sequenceprotein functionprotein structurereceptorsarcomasolid state nuclear magnetic resonancestereochemistrysynthetic peptide
中文摘要
点击翻译按钮获取中文摘要
英文摘要
SUMMARY
We want to elucidate modes of polypeptide assembly that are important for biological
function and associated with human disease but are difficult to characterize via standard
experimental approaches. In each case, we wish to understand the non-covalent forces that
underlie the assembly mode. Because of differences among the types of assembly we are
studying, the experimental approaches we adopt are variable.
One goal is to characterize quaternary structures formed by single-pass transmembrane
(SPTM) α-helices that are constituents of cell-surface receptors, such as receptor tyrosine
kinases (RTKs) and activating immune receptors. These receptors form oligomers, and
rearrangement of oligomer geometry transmits the signal. Crystallographic data are available in
only for the SPTM α-helix of immune receptor component DAP12. There is no high-resolution
structural information for alternative geometries of SPTM α-helix assemblies that are thought to
be associated with different receptor activation states. We are applying racemic crystallization
and micro-electron diffraction (via collaboration) to this structural challenge, and we are
exploring protein-based “picodiscs” as hosts for SPTM α-helix assemblies.
A second goal is to understand how sequence, composition and dimensions influence
stability of polypeptides in the amyloid state. The β-sheet-rich structures that are common to
disease-associated amyloid fibrils are distinct from tertiary and quaternary structures commonly
found among soluble proteins. The techniques commonly used to elucidate sequence-stability
relationships among soluble proteins are not readily applied to amyloid fibrils; therefore, we are
developing a soluble model system for the amyloid state, which we will exploit to ask
fundamental questions about amyloid state stability.
The third goal is to understand the forces that lead to liquid-liquid phase separation
(LLPS) mediated by proteins in the FUS (“fused in sarcoma”) family. The loose associations
between polypeptide chains in the protein-rich liquid phase are not well understood. Such
phases can transition to amyloid-like assemblies, which forms a strong connection between our
second and third goals. These more ordered assemblies are associated with illnesses such as
ALS. We seek to model LLPS of FUS family proteins with synthetic peptides in order to conduct
incisive tests of recent mechanistic proposals and to evaluate the role of amino acid sequence
and stereochemistry in LLPS and the transition to more ordered and pathogenic assemblies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Polymeric Agents for the Treatment of Clostridium difficile Infections
-
批准号:9186498
-
项目类别:
-
资助金额:$21.41万
-
财政年份:2015
-
负责人:SAMUEL H. GELLMAN
-
依托单位:
Polymeric Agents for the Treatment of Clostridium difficile Infections
-
批准号:9021375
-
项目类别:
-
资助金额:$20.05万
-
财政年份:2015
-
负责人:SAMUEL H. GELLMAN
-
依托单位:
Design and analysis of random copolymers with antimicrobial activity
-
批准号:8041852
-
项目类别:
-
资助金额:$31.69万
-
财政年份:2011
-
负责人:SAMUEL H. GELLMAN
-
依托单位:
Nylon-3 Copolymers as Synthetic Cell-Adhesive Moieties for Tissue Engineering
-
批准号:8240031
-
项目类别:
-
资助金额:$18.4万
-
财政年份:2011
-
负责人:SAMUEL H. GELLMAN
-
依托单位:
Design and Analysis of Random Copolymers with Antimicrobial Activity
-
批准号:9196509
-
项目类别:
-
资助金额:$33.42万
-
财政年份:2011
-
负责人:SAMUEL H. GELLMAN
-
依托单位:
Design and analysis of random copolymers with antimicrobial activity
-
批准号:8301533
-
项目类别:
-
资助金额:$31.69万
-
财政年份:2011
-
负责人:SAMUEL H. GELLMAN
-
依托单位:
Design and analysis of random copolymers with antimicrobial activity
-
批准号:8708892
-
项目类别:
-
资助金额:$31.69万
-
财政年份:2011
-
负责人:SAMUEL H. GELLMAN
-
依托单位:
Design and analysis of random copolymers with antimicrobial activity
-
批准号:8513354
-
项目类别:
-
资助金额:$30.58万
-
财政年份:2011
-
负责人:SAMUEL H. GELLMAN
-
依托单位:
Nylon-3 Copolymers as Synthetic Cell-Adhesive Moieties for Tissue Engineering
-
批准号:8090829
-
项目类别:
-
资助金额:$20.88万
-
财政年份:2011
-
负责人:SAMUEL H. GELLMAN
-
依托单位:
Determinants of Fold Stability in Proteins and Analogues
-
批准号:7926143
-
项目类别:
-
资助金额:$9.99万
-
财政年份:2009
-
负责人:SAMUEL H. GELLMAN
-
依托单位:
2010 Chemistry and Biology of Peptides Gordon Research Conference
-
批准号:7804208
-
项目类别:
-
资助金额:$0.5万
-
财政年份:2009
-
负责人:SAMUEL H. GELLMAN
-
依托单位:
MALDI TOF/TOF Mass Spectrometer
-
批准号:7388564
-
项目类别:
-
资助金额:$37.65万
-
财政年份:2008
-
负责人:SAMUEL H. GELLMAN
-
依托单位:
VILLIN HEADPIECE SUBDOMAIN (VHP) STUDY
-
批准号:7598694
-
项目类别:
-
资助金额:$0.12万
-
财政年份:2007
-
负责人:SAMUEL H. GELLMAN
-
依托单位:
STUDIES ON BETA-AMINOACID OLIGOMERS
-
批准号:7598802
-
项目类别:
-
资助金额:$0.04万
-
财政年份:2007
-
负责人:SAMUEL H. GELLMAN
-
依托单位:
TRAINING IN THE USE OF BRUKER AND VARIAN SPECTROMETERS AND NMR
-
批准号:7598726
-
项目类别:
-
资助金额:$0.01万
-
财政年份:2007
-
负责人:SAMUEL H. GELLMAN
-
依托单位:
ROLE OF GLYCOPROTEIN B IN HCMV INFECTION
-
批准号:7598725
-
项目类别:
-
资助金额:$0.03万
-
财政年份:2007
-
负责人:SAMUEL H. GELLMAN
-
依托单位:
PEPTIDE SYNTHESIZER: HEART
-
批准号:7166303
-
项目类别:
-
资助金额:$2.44万
-
财政年份:2005
-
负责人:SAMUEL H. GELLMAN
-
依托单位:
PEPTIDE SYNTHESIZER: GLAUCOMA
-
批准号:7166299
-
项目类别:
-
资助金额:$2.44万
-
财政年份:2005
-
负责人:SAMUEL H. GELLMAN
-
依托单位:
PEPTIDE SYNTHESIZER: CMV, HERPES, BACTERIAL PROTEINS
-
批准号:7166300
-
项目类别:
-
资助金额:$2.44万
-
财政年份:2005
-
负责人:SAMUEL H. GELLMAN
-
依托单位:
Acquisition of Peptide Synthesizer for Core Facility
-
批准号:6876442
-
项目类别:
-
资助金额:$12.2万
-
财政年份:2005
-
负责人:SAMUEL H. GELLMAN
-
依托单位:
海外基金